1 March 2021 in International Journal of Pharmaceutics
17 April 2020 in RSC Advances
Microfluidic devices, allowing superior control over the spatial and temporal distribution of chemical substances and high process reproducibility, are nowadays essential in various research areas and industrial fields where the traditional “macroscopic” approach was no longer able to keep up with the increasing demands of high-end applications. In the present work, internal mixing of droplets formed by a flow-focusing X-junction at constant flow rates of both phases for three different channel heights (i.e. 20, 40 and 60 μm) was investigated and characterised. Both experimental methods and 3D CFD simulations were employed in order to resolve governing factors having an impact on internal mixing and homogenization time of model tracers inside of droplet reactors. Additionally, the influence of channel height on internal mixing was experimentally studied for continuous preparation of iron oxide nanoparticles by co-precipitation reaction. Since the initial nucleation phase is strongly affected by mixing and spatial distribution of all reactants, the final particle size and particle size distribution (PSD) can be used as direct indicators of mixing performance. It has been demonstrated that the smallest 20 μm channels provided narrower PSD and smaller particle mean size compared to higher channels.
1 February 2018 in Chemical Engineering Journal
4 November 2023 in International Journal of Pharmaceutics
8 February 2021 in Molecular Systems Design & Engineering
Liposomal formulations can be advantageous in many scenarios such as targeted delivery to reduce the systemic toxicity of highly potent active pharmaceutical ingredients (APIs), to increase drug bioavailability by prolonging systemic circulation, to protect labile APIs from degradation in the gastrointestinal tract, or to improve skin permeation in dermal delivery. However, not all APIs are suitable for encapsulation in liposomes. Some of the issues are too high permeability of the API across the lipid bilayer, which may lead to premature leakage, too low permeability, which may hinder the drug release process, or too strong membrane affinity, which may reduce the overall efficacy of drug release from liposomes. Since the most reliable way to test API encapsulation and release from liposomes so far has been experimental, an in silico model capable of predicting API transport across the lipid bilayer might accelerate formulation development. In this work, we demonstrate a new in silico approach to compute the temperature-dependent permeability of a set of compounds across the bilayer of virtual liposomes constructed by molecular dynamics simulation. To validate this approach, we have conducted a series of experiments confirming the model predictions using a homologous series of fluorescent dyes. Based on the performance of individual molecules, we have defined a set of selection criteria for identifying compatible APIs for stable encapsulation and thermally controlled release from liposomes. To further demonstrate the in silico-based methodology, we have screened the DrugBank database, identified potent drugs suitable for liposome encapsulation and successfully carried out the loading and thermal release of one of them – the antimicrobial compound cycloserine.
27 April 2021 in Organic & Biomolecular Chemistry
Fully acetylated deoxyfluorinated hexosamine analogues and non-fluorinated 3,4,6-tri-O-acylated N-acetyl-hexosamine hemiacetals have previously been shown to display moderate anti-proliferative activity. We prepared a set of deoxyfluorinated GlcNAc and GalNAc hemiacetals that comprised both features: O-acylation at the non-anomeric positions with an acetyl, propionyl and butanoyl group, and deoxyfluorination at selected positions. Determination of the in vitro cytotoxicity towards the MDA-MB-231 breast cancer and HEK-293 cell lines showed that deoxyfluorination enhanced cytotoxicity in most analogues. Increasing the ester alkyl chain length had a variable effect on the cytotoxicity of fluoro analogues, which contrasted with non-fluorinated hemiacetals where butanoyl derivatives had always higher cytotoxicity than acetates. Reaction with 2-phenylethanethiol indicated that the recently described S-glyco-modification is an unlikely cause of cytotoxicity.